title: Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration.
abstract: To identify the roles of vesicular gamma-aminobutyric acid (GABA) transporter (VGAT) in epileptogenesis and the recovery mechanisms in spontaneous seizure, we conducted a chronological and comparative analysis of VGAT expression. VGAT immunoreactivity was stronger in the seizure resistant group than that in the pre-seizure group of seizure sensitive (SS) gerbils. In 3 h postictal group, the density of VGAT immunoreactivity was significantly increased in the hippocampus, as compared to pre-seizure group. In 24 h postictal group, VGAT immunodensity had recovered to its pre-seizure level. In addition, VGAT immunoreactivity in the hippocampus was also increased by vigabatrin (GVG) administration. These results suggest that decreased VGAT expression in the SS gerbil hippocampus may affect epileptogenesis in this animal, and that the subsequent alteration in its expression induced by seizure and the administration of GVG may reflect a modulation of GABA release to alleviate seizure activity.
authors.affiliation: Department of Anatomy, College of Medicine, Hallym University, Chunchon, Kangwon-Do 200-702, South Korea. tckang@hallym.ac.kr
authors.forename: Tae Cheon
authors.initials: TC
authors.lastname: Kang
authors.forename: Sung Jin
authors.initials: SJ
authors.lastname: An
authors.forename: Seung Kook
authors.initials: SK
authors.lastname: Park
authors.forename: In Koo
authors.initials: IK
authors.lastname: Hwang
authors.forename: Jae Chun
authors.initials: JC
authors.lastname: Bae
authors.forename: Moo Ho
authors.initials: MH
authors.lastname: Won
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002352:Carrier Proteins / Q000187:drug effects* / Q000378:metabolism*; D050485:GABA Plasma Membrane Transport Proteins; D005849:Gerbillinae; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism*; D008565:Membrane Proteins / Q000187:drug effects* / Q000378:metabolism*; D026901:Membrane Transport Proteins; D027361:Organic Anion Transporters; D012640:Seizures / Q000188:drug therapy / Q000378:metabolism*; D013997:Time Factors; D015854:Up-Regulation; D020888:Vigabatrin / Q000494:pharmacology*
chemical_list: D000927:Anticonvulsants; D002352:Carrier Proteins; D050485:GABA Plasma Membrane Transport Proteins; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D027361:Organic Anion Transporters; D020888:Vigabatrin